Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes
Related Experiment Video
Updated: Sep 9, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 16, 2013
J M Pascussi1, S Gerbal-Chaloin, L Pichard-Garcia
1INSERM U128, IFR24, 1919 Route de Mende, Montpellier, 34293, France.
Abstract:
The marked impairment of hepatic drug metabolism during inflammation and infections has been known for many years and shown to result from down-regulation of cytochrome P450s (CYP) by cytokines. However, the mechanism of this repression is unknown. Using primary cultures of human hepatocytes, we show here that interleukin-6 (IL-6) rapidly and markedly decreases the expression of PXR (pregnane X receptor) and CAR (constitutively activated receptor) mRNAs, but does not affect the levels of dioxin receptor and glucocorticoid receptor mRNA. In parallel, IL-6 decreases both rifampicin- and phenobarbital-mediated induction of CYP2B6, CYP2C8, CYP2C9, and CYP3A4. As the transcriptional activity of PXR and CAR is not affected by IL-6 in cell-based reporter assays, our data suggest that the loss of CYP2 and CYP3 inducibility results from the negative regulation of PXR and CAR gene expression by this cytokine.
Insights
Inflammation reduces drug metabolism by decreasing cytochrome P450s (CYP). Interleukin-6 (IL-6) lowers pregnane X receptor (PXR) and constitutively activated receptor (CAR) expression, impairing CYP induction.
Area of Science:
- Biochemistry
- Pharmacology
- Molecular Biology
Background:
- Hepatic drug metabolism is impaired during inflammation and infection.
- This impairment is linked to cytokine-mediated downregulation of cytochrome P450s (CYP).
- The precise mechanism of this CYP repression remains unknown.
Purpose of the Study:
- To investigate the mechanism by which interleukin-6 (IL-6) represses hepatic drug metabolism.
- To determine the effect of IL-6 on the expression of key drug-metabolizing enzymes and their regulatory receptors.
Main Methods:
- Primary cultures of human hepatocytes were treated with IL-6.
- Expression levels of PXR, CAR, dioxin receptor, and glucocorticoid receptor mRNAs were quantified.
- CYP induction by rifampicin and phenobarbital was measured.
- Transcriptional activity of PXR and CAR was assessed using cell-based reporter assays.
Main Results:
- IL-6 significantly decreased the mRNA expression of PXR and CAR.
- IL-6 did not affect the mRNA levels of the dioxin receptor or glucocorticoid receptor.
- IL-6 reduced the induction of CYP2B6, CYP2C8, CYP2C9, and CYP3A4 by rifampicin and phenobarbital.
- The transcriptional activity of PXR and CAR was not directly inhibited by IL-6.
Conclusions:
- IL-6 negatively regulates the gene expression of PXR and CAR.
- This downregulation of PXR and CAR by IL-6 leads to the loss of inducibility of key drug-metabolizing CYP enzymes.
- The findings elucidate a mechanism for impaired drug metabolism during inflammatory conditions.
Related Concept Videos
Regulation of Nuclear Protein Sorting
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Regulation of the Unfolded Protein Response
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

